fbpx
Medical Innovation Exchange

Welcome to New (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer deal

https://www.fiercebiotech.com/biotech/after-selling-its-blockbuster-migraine-program-can-new-biohaven-strike-gold-twice

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.